Login
Join for Free

All Posts

Pharmaceutical quality professionals investigate manufacturing deviations using root cause analysis to identify underlying causes, strengthen CAPA effectiveness, and maintain GMP compliance.
Picture of Ershad Moradi

Ershad Moradi

Content Marketing Specialist

Root Cause Analysis in Pharmaceutical Industry: 6 Powerful Methods in 2026

Explore 6 powerful root cause analysis methods in pharma to investigate deviations, strengthen CAPA, ensure GMP compliance, and protect patient safety.
  • Compliance, Quality Assurance, Regulatory
Three pharmaceutical professionals in cleanroom attire review a batch record together in a GMP manufacturing facility.
Picture of Ershad Moradi

Ershad Moradi

Content Marketing Specialist

Quality Culture in Pharma Industry 2026: Proven Ways to Build Trust

Explore how to build a strong quality culture in the pharmaceutical industry in 2026 through leadership commitment, ICH Q10 principles, meaningful GMP metrics, effective CAPA, and continuous improvement.
  • Compliance, Quality Assurance, Regulatory
Picture of Ershad Moradi

Ershad Moradi

Content Marketing Specialist

GMP Training Effectiveness 2026: Proven Ways to Build Real Competence

GMP training effectiveness goes beyond attendance records and quiz scores. Learn how role-based assessments, on-the-job observation, and meaningful KPIs help verify employee competence, strengthen training records, and address recurring performance gaps across pharmaceutical operations.
  • Audit, Blog, FDA, Quality Assurance, Regulatory
Picture of Ershad Moradi

Ershad Moradi

Content Marketing Specialist

GMP Audit Checklist 2026: The Essential Guide for Risk-Based Audits

Master your GMP Audit Checklist with a practical, risk-based approach to pharmaceutical self-inspections. Explore five essential audit steps, FDA’s six-system model, GMP documentation and evidence sampling, audit findings, CAPA tracking, and effectiveness verification to strengthen compliance and inspection readiness.
  • Audit, Blog, FDA, Quality Assurance, Regulatory
FDA and EMA regulatory review illustration showing medical plausibility assessments, scientific checklists, a medicine vial, and rare disease patients
Picture of Mahtab Shardi

Mahtab Shardi

Orphan Drug Designation in 2026: FDA and EMA Eligibility Criteria

Discover how orphan drug designation works in 2026. Compare FDA and EMA eligibility criteria, rare disease prevalence thresholds, scientific evidence requirements, and regulatory incentives. Learn what pharmaceutical sponsors need to prepare for successful regulatory submissions
  • Blog, Quality Assurance, Regulatory
Quality assurance specialist reviewing a Certificate of Suitability with digital verification icons in a pharmaceutical manufacturing facility
Picture of Mahtab Shardi

Mahtab Shardi

CEP certificate in pharma: What QA Must Verify in 2026

Learn how QA teams verify EDQM certificates, assess API suppliers, and prepare for GMP inspections. This guide explains CEP 2.0 updates, impurity controls, and essential records that help maintain regulatory compliance and inspection readiness across pharmaceutical manufacturing operations.
  • Blog, Quality Assurance, Regulatory
CAPA and Deviation Review in Pharma
Picture of Ershad Moradi

Ershad Moradi

Content Marketing Specialist

GMP Inspection Readiness : A Proven Audit Guide in 2026

GMP inspection readiness means showing that your pharmaceutical quality systems work every day. This practical guide walks QA, QC and site leaders through a five-step, risk-based preparation framework, with priority evidence to review, mock inspection tips, CAPA guidance and answers to common inspection questions.
  • Blog, FDA, Quality Assurance, Quality Control, Regulatory
Pharmaceutical Team at Vial Filling Line
Picture of Ershad Moradi

Ershad Moradi

Content Marketing Specialist

GMP Training Matrix in 2026: How to Build an Audit-Ready, Role-Based Training System

Learn how to build a GMP training matrix that links pharma team roles to SOPs, records competency evidence, tracks retraining, and supports inspection readiness.
  • Blog, FDA, Quality Control, Regulatory
Picture of Ershad Moradi

Ershad Moradi

Content Marketing Specialist

Universities vs Pharmuni in 2026: Faster Pharma Career Readiness

Universities provide formal degrees, research depth and academic credibility. Pharmuni adds faster pharma-specific upskilling, assessments, Career Paths, CV tools and job-readiness support. Here is how the two models differ—and when using both makes sense.
  • Blog, FDA, Quality Control, Regulatory
Picture of Ershad Moradi

Ershad Moradi

Content Marketing Specialist

Innopharma Education vs Pharmuni in 2026: The Ultimate Career Game-Changer?

Innopharma Education offers structured, accredited life-science programmes with formal academic pathways and career support. Pharmuni is a lighter, self-paced pharma career ecosystem combining courses, assessments, Career Paths, CV tools, and job matching. This guide compares where each model fits best.
  • Blog, FDA, Quality Control, Regulatory